All Episodes

Episode 3: Genetic Counseling and Religion Podcast Series - The Church of Jesus Christ of Latter-day Saints

Episode 2: Genetic Counselling and Religion Podcast Series - Hindu American Community

Episode 1: Genetic Counselling and Religion Podcast Series - Orthodox Judaism

Episode 5: CDH1 Chats: Digesting Tough Conversations

Episode 4: Navigating Gynecologic Cancer Risk in Lynch Syndrome: A Closer Look at Evolving Guidelines

Episode 3: Research Collaboration Podcast Series - International Replication Repair Deficiency Consortium

Episode 2: Research Collaboration Podcast Series - Gastric CDH1 Multicenter consortium

Episode 1: Research Collaboration Podcast Series - LINEAGE consortium.

Episode 5 - Season 7: Síndrome de Lynch, vía acelerada del «Big Bang» y riesgo de cáncer

Episode 5 - Season 7: Lynch syndrome, the accelerated “Big Bang” pathway and cancer risk

Episode 4: Season 7: Acceso a la atención genética en comunidades diversas: La experiencia latinoamericana (Versión española)

Episode 4: Season 7: Access to Genetic Care in Diverse Communities: The Latin American Experience (English version)

Episode 2: Previous CGA-IGC Grant recipients - Giovana Torrezan, PhD

Episode 3: Season 7: Mentorship - A Shared Experience

Episode 2: Season 7 - Episode 2: Decisional regret post-prophylactic gastrectomy for Hereditary Diffuse Gastric Cancer (HDGC)

Episode 1: Season 7 - Episode 1: Constitutional MLH1 hypermethylation

Episode 5: Episode 5: S.6 Ep.5 Position statement of the International Society for Gastrointestinal Hereditary Tumours (InSiGHT) on APC I1307K and Cancer Risk

Episode 4: Episode 4: S.6 Ep.4 Fight CRC Advocate Danielle Ripley-Burgess: "Life After Total Proctocolectomy in Lynch Syndrome”

Episode 3: Episode 3: S.6 Ep.3 Clinical characteristics of pancreatic and biliary tract cancers in Lynch syndrome: A retrospective analysis from the Finnish National Lynch Syndrome Research Registry

Episode 2: Episode 2: S.6 Ep.2 Considerations for individuals with Hereditary Diffuse Gastric Cancer Syndrome when considering a prophylactic gastrectomy

Episode 1: Previous CGA-IGC Grant recipients - Dr. Allison Burton-Chase

Episode 1: Episode 1: S.6 Ep.1 Cancer Prevention with Resistant Starch in Lynch (CAPP2 Trial)

Episode 8: S.5 Ep.8 PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer

Episode 7: S.5 Ep.7 Evidence for Gastric Cancer Surveillance in Lynch Syndrome

Episode 6: S.5 Ep.6 Is it Time for Universal Germline Genetic Testing for All GI Cancers? A podcast debate!

Episode 5: S.5 Ep.5 The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival

Episode 4: S.5 Ep.4 Evaluation of Urinalysis-Based Screening for Urothelial Carcinoma in Patients With Lynch Syndrome

Episode 3: S.5 Ep.3 Patterns of germline and somatic testing after universal tumor screening for Lynch syndrome: A clinical practice survey of active members of the CGA-IGC

Episode 2: S.5 Ep.2 EUS - based Pancreatic Cancer Surveillance in BRCA1/BRCA2/PALB2/ATM Carriers without a Family History of Pancreatic Cancer

Episode 1: S.5 Ep.1 Creating Breast and Gynecologic Cancer Guidelines for Transgender Patients With BRCA Mutations

Episode 22: S.4 Ep.5 Impact of Patients' Companions on Clinical Encounters Between Black Patients and Their Non-Black Oncologists

Episode 21: S.4 Ep.4 Prospective Statewide Study of Universal Screening for Hereditary Colorectal Cancer: The Ohio Colorectal Cancer Prevention Initiative

Episode 20: S.4 Ep. 3 Naproxen Chemoprevention Promotes Immune Activation in Lynch Syndrome Colorectal Mucosa

Episode 19: S.4 Ep. 2 Phenotypic Differences in Juvenile Polyposis Syndrome With or Without a Disease-causing SMAD4/BMPR1A Variant

Episode 18: S.4 Ep. 1 Eflornithine plus Sulindac for Prevention of Progression in Familial Adenomatous Polyposis

S.3 Ep.6 Hereditary diffuse gastric cancer: updated clinical practice guidelines

S.3 Ep. 5 Cancer prevention with aspirin in hereditary colorectal cancer (Lynch Syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial

S.3 Ep. 4 Highlights from the 2020 ASCO Annual Meeting

S.3 Ep.3: Updates in the Evaluation and Management of Serrated Polyposis Syndrome (SPS)

S.3 Ep.2: A Multi-Institutional Cohort of Therapy-Associated Polyposis in Childhood and Young Adulthood Cancer Survivors

S3. Ep.1: Collaborative Group of the Americas on Inherited Gastrointestinal Cancer Position statement on multigene panel testing for patients with colorectal cancer and/or polyposis

S2 Ep.6: Transitioning from Pediatric to Adult Care for Patients with FAP

S2. Ep.5: Thyroid disease in FAP

S2 Ep.4: Desmoid disease in FAP

S2 Ep.3: Management of Duodenal Neoplasia in FAP

S2 Ep.2: Gastric Adenocarcinoma and Proximal Polyposis of the Stomach (GAPPS)

S2 Ep.1: Gastric Polyps and Cancer in FAP

S1 Ep.5: Breast Cancer and Lynch

S1 Ep.4: Urologic Risks in Lynch

S1 Ep.3: Gynecologic Risks in Lynch

S1 Ep.2: Cancer Risks in Lynch Part II

S1 Ep.1: Cancer Risks in Lynch Part I